Acadia Pharmaceuticals (ACAD) Q2 2026 Earnings Call Transcript

Revenue hit $308 million with 17% growth, driven by DAYBUE and NUPLAZID demand.

CryptoAlerta — análise de criptomoedas e mercado em tempo real